Decreased urinary secretion of belotecan in folic acid-induced acute renal failure rats due to down-regulation of Oat1 and Bcrp

References

• Aleksunes LM, Augustine LM, Scheffer GL, Cherrington NJ, Manautou JE. (2008). Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment. Toxicology 250(2–3):82–8.
   PubMed Web of Science ®Google Scholar
• Bosch RJ, Woolf AS, Fine LG. (1993). Gene transfer into the mammalian kidney: direct retrovirus-transduction of regenerating tubular epithelial cells. Exp Nephrol 1(1):49–54.
   PubMedGoogle Scholar
• Bringhurst FR, Juppner H, Guo J, Urena P, Potts JT, Jr., Kronenberg HM, Abou-Samra AB, Segre GV. (1993). Cloned, stably expressed parathyroid hormone (PTH)/PTH-related peptide receptors activate multiple messenger signals and biological responses in LLC-PK1 kidney cells. Endocrinology 132(5):2090–8.
   PubMed Web of Science ®Google Scholar
• Buist SC, Cherrington NJ, Choudhuri S, Hartley DP, Klaassen CD. (2002). Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 301(1):145–51.
   PubMed Web of Science ®Google Scholar
• Cheng CW, Rifai A, Ka SM, Shui HA, Lin YF, Lee WH, Chen A. (2005). Calcium-binding proteins annexin A2 and S100A6 are sensors of tubular injury and recovery in acute renal failure. Kidney Int 68(6):2694–703.
   PubMed Web of Science ®Google Scholar
• Chiou WL. (1978). Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level–time curve. J Pharmacokinet Biopharm 6:539–46.
   PubMedGoogle Scholar
• Crul M. (2003). CKD-602. Chong kun dang. Curr Opin Investig Drug 4(12):1455–9.
   PubMedGoogle Scholar
• Dai C, Yang J, Liu Y. (2002). Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol 13(2):411–22.
   PubMed Web of Science ®Google Scholar
• Doi K, Okamoto K, Negishi K, Suzuki Y, Nakao A, Fujita T, Toda A, Yokomizo T, Kita Y, Kihara Y, Ishii S, Shimizu T, Noiri E. (2006). Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am J Pathol 168(5):1413–24.
   PubMed Web of Science ®Google Scholar
• Fang TC, Alison MR, Cook HT, Jeffery R, Wright NA, Poulsom R. (2005). Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. J Am Soc Nephrol 16(6):1723–32.
   PubMed Web of Science ®Google Scholar
• Fiaschi-Taesch NM, Santos S, Reddy V, Van Why SK, Philbrick WF, Ortega A, Esbrit P, Orloff JJ, Garcia-Ocana A. (2004). Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: the efficacy of parathyroid hormone-related protein and hepatocyte growth factor. J Am Soc Nephrol 15(1):112–25.
   PubMed Web of Science ®Google Scholar
• Gibaldi M, Perrier D. (1982). Pharmacokinetics. Marcel Dekker; Washington (DC). p. 409–17.
   Google Scholar
• Hilgendorf C, Ahlin G, Seithel A, Artursson P, Ungell AL, Karlsson J. (2007). Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos 35(8):1333–40.
   PubMed Web of Science ®Google Scholar
• Huls M, Brown CD, Windass AS, Sayer R, Van den Heuvel JJ, Heemskerk S, Russel FG, Masereeuw R. (2008). The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int 73(2):220–5.
   PubMedGoogle Scholar
• Jin Q-R, Kim I-W, Choi M-K, Shim W-S, Tian G-Y, Lee S, Lee J, Kim D-D, Chung S-J, Shim C-K. (2009). Determination of belotecan in the plasma, bile, and urine of rats by high-performance liquid chromatography with fluorescence detection and its application to a pharmacokinetic study. Analyt Lett 42(1):68–83.
   Google Scholar
• Jones CH, Warren CW. (1996). Acute renal failure secondary to hypercalcaemia reversible after resection of a benign ovarian teratoma. Nephrol Dial Transplant 11(9):1860–61.
   PubMed Web of Science ®Google Scholar
• Jonker JW, Smit JW, Brinkhuis RF, Maliepaard M, Beijnen JH, Schellens JH, Schinkel AH. (2000). Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 92:1651–6.
   PubMed Web of Science ®Google Scholar
• Jung KY, Takeda M, Kim DK, Tojo A, Narikawa S, Yoo BS, Hosoyamada M, Cha SH, Sekine T, Endou H. (2001). Characterization of ochratoxin A transport by human organic anion transporters. Life Sci 69(18):2123–35.
   PubMed Web of Science ®Google Scholar
• Kino I, Kato Y, Lin JH, Sugiyama Y. (1999). Renal handling of biphosphonate alendronate in rats. Biopharm Drug Dispos 20:193–8.
   PubMed Web of Science ®Google Scholar
• Lameire NH, Flombaum CD, Moreau D, Ronco C. (2005). Acute renal failure in cancer patients. Ann Med 37(1):13–25.
   PubMed Web of Science ®Google Scholar
• Leon S, Susanna W-P, Andrew BCY. (2005). Applied Biopharmaceutics & Pharmacokinetics, fifth edition. pp 132–147.
   Google Scholar
• Li H, Jin HE, Kim W, Han YH, Kim DD, Chung SJ, Shim CK. (2008). Involvement of P-glycoprotein, multidrug resistance protein 2 and breast cancer resistance protein in the transport of belotecan and topotecan in Caco-2 and MDCKII cells. Pharm Res 25:2601–12.
   PubMed Web of Science ®Google Scholar
• Mullin EM, Bonar RA, Paulson DF. (1976). Acute tubular necrosis. An experimental model detailing the biochemical events accompanying renal injury and recovery. Invest Urol 13(4):289–94.
   PubMedGoogle Scholar
• Nakagawa H, Hirata T, Terada T, Jutabha P, Miura D, Harada KH, Inoue K, Anzai N, Endou H, Inui K, Kanai Y, Koizumi A. (2008). Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid. Basic Clin Pharmacol Toxicol 103(1):1–8.
   PubMed Web of Science ®Google Scholar
• Ortega A, Ramila D, Ardura JA, Esteban V, Ruiz-Ortega M, Barat A, Gazapo R, Bosch RJ, Esbrit P. (2006). Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity. J Am Soc Nephrol 17(6):1594–603.
   PubMed Web of Science ®Google Scholar
• Ortega A, Ramila D, Izquierdo A, Gonzalez L, Barat A, Gazapo R, Bosch RJ, Esbrit P. (2005). Role of the renin–angiotensin system on the parathyroid hormone-related protein overexpression induced by nephrotoxic acute renal failure in the rat. J Am Soc Nephrol 16(4):939–49.
   PubMed Web of Science ®Google Scholar
• Ortiz A, Lorz C, Catalan MP, Danoff TM, Yamasaki Y, Egido J, Neilson EG. (2000). Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int 57(3):969–81.
   PubMed Web of Science ®Google Scholar
• Ose A, Kusuhara H, Yamatsugu K, Kanai M, Shibasaki M, Fujita T, Yamamoto A, Sugiyama Y. (2008). P-glycoprotein restricts the penetration of oseltamivir across the blood–brain barrier. Drug Metab Dispos 36(2):427–34.
   PubMed Web of Science ®Google Scholar
• Padanilam BJ. (2001). Induction and subcellular localization of protein kinase C isozymes following renal ischemia. Kidney Int 59(5):1789–97.
   PubMed Web of Science ®Google Scholar
• Santos S, Bosch RJ, Ortega A, Largo R, Fernandez-Agullo T, Gazapo R, Egido J, Esbrit P. (2001). Up-regulation of parathyroid hormone-related protein in folic acid-induced acute renal failure. Kidney Int 60(3):982–95.
   PubMed Web of Science ®Google Scholar
• Shim WS, Park JH, Ahn SJ, Han L, Jin QR, Li H, Choi MK, Kim DD, Chung SJ, Shim CK. (2008). Testosterone-independent down-regulation of Oct2 in the kidney medulla from a uranyl nitrate-induced rat model of acute renal failure: Effects on distribution of a model organic cation, tetraethylammonium. J Pharm Sci 98(2):739–47.
   Google Scholar
• Sun H, Frassetto L, Benet LZ. (2006). Effects of renal failure on drug transport and metabolism. Pharmacol Ther 109(1–2):1–11.
   PubMed Web of Science ®Google Scholar
• Szczypka MS, Westover AJ, Clouthier SG, Ferrara JL, Humes HD. (2005). Rare incorporation of bone marrow-derived cells into kidney after folic acid-induced injury. Stem Cell 23(1):44–54.
   PubMed Web of Science ®Google Scholar
• Tahara H, Shono M, Kusuhara H, Kinoshita H, Fuse E, Takadate A, Otagiri M, Sugiyama Y. (2005). Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney. Pharm Res 22(4):647–60.
   PubMed Web of Science ®Google Scholar
• Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, Suchy FJ, Keppler D, Boyer JL. (1997). The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113(1):255–64.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration (USFDA). (2006). Guidance for industry, drug interaction studies — study design, data analysis, and implications for dosing and labeling. Washington (DC): USFDA.
   Google Scholar
• Uwai Y, Okuda M, Takami K, Hashimoto Y, Inui K. (1998). Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney. FEBS Lett 438(3):321–4.
   PubMed Web of Science ®Google Scholar
• Wan B, Hao L, Qiu Y, Sun Z, Cao Q, Zhang Y, Zhu T, Wang H. (2006). Blocking tumor necrosis factor-alpha inhibits folic acid-induced acute renal failure. Exp Mol Pathol 81(3):211–16.
   PubMed Web of Science ®Google Scholar